UPDATE: Cytosorbents (CTSO) Tops Q2 EPS View

(Updated - August 14, 2015 8:01 AM EDT) (EPS corrected)

Cytosorbents (NASDAQ: CTSO) reported Q2 EPS of $0.05, which was better than the analyst estimate of ($0.11). Revenue for the quarter came in at $733 thousand versus the consensus estimate of $910 thousand.

For earnings history and earnings-related data on Cytosorbents (CTSO) click here.

You May Also Be Interested In

• SLM (SLM) Misses Q2 EPS by 16c; offers guidance
• Oak Valley Bancorp (OVLY) Tops Q2 EPS by 61c
• Business First Bancshares, Inc. (BFST) Tops Q2 EPS by 1c